+ Follow ALFA Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 814597
[Title] => The Guardian angel (19)
[Summary] => “ALFA?” Nakalapit na si Eric sa dalagang bulag.
[DatePublished] => 2012-10-13 00:00:00
[ColumnID] => 135886
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Pang Masa
[SectionUrl] => pang-masa
[URL] =>
)
[1] => Array
(
[ArticleID] => 487993
[Title] => Making good in a business of helping others
[Summary] => “I used to believe if you have money you can easily afford to get through an illness, but realized not if you are a dialysis patient,” thus said housewife Josephine Patricio, who has experienced the agony of taking care of his husband Lito who suffered kidney failure and is now undergoing dialysis treatments on its fourth year.
[DatePublished] => 2009-07-20 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
[2] => Array
(
[ArticleID] => 461231
[Title] => Through cell regeneration: Alfa brings renewed health and longer life
[Summary] => MANILA, Philippines - Do you desire to enjoy good health, long life and youthfulness?
[DatePublished] => 2009-04-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
[3] => Array
(
[ArticleID] => 410611
[Title] => Kapalpakan ng FEDEX
[Summary] => SA unang patustada pa lamang ni Alfa Mae Comendador ay malaki na ang tiwala nito sa Federal Express dahil ang company ...
[DatePublished] => 2008-10-28 00:00:00
[ColumnID] => 135127
[Focus] => 0
[AuthorID] => 1096558
[AuthorName] => Butch M. Quejada
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[4] => Array
(
[ArticleID] => 16664
[Title] => Tolerability key to success of hepatitis C treatment
[Summary] =>
[DatePublished] => 2007-09-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 300282
[Title] => New hepa B treatment outdoes standard care
[Summary] => A recent study shows that peginterferon alfa 2-a, a new hepatitis B treatment, provides a significantly greater proportion of patients with lasting remission compared to lamivudine, the current standard of care.
A study was conducted among patients with HbeAG positive hepatitis B, the subtype of the disease which affects majority of hepatitis B patients worldwide.
[DatePublished] => 2005-10-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 274759
[Title] => New hepa B treatment cited
[Summary] => At the recent 14th biennial conference of the Asian Pacific Association for the Study of the Liver, a new hepatitis B treatment option was cited.
Peginterferon alfa 2-a has been shown to treat both HbeAG-positive and HbeAG-negative chronic hepatitis B, thus removing the need for daily and potentially life-long therapy for the disease.
The studies presented during the conference showed that peginterferon alfa 2-a is superior to lamivudine, the most commonly prescribed medication for hepatitis B.
[DatePublished] => 2005-04-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 267041
[Title] => Current status of HCV therapy
[Summary] => Major advances have been made in the treatment of chronic hepatitis C during the last 10 years, but major challenges remain, since treatment with pegylated interferons and ribavirin is effective in only around 55 percent of patients. Newer therapies are needed for the increasing numbers of patients who do not respond to relapse after current treatments with pegylated in interferons and ribavirin.
[DatePublished] => 2004-12-05 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[8] => Array
(
[ArticleID] => 221854
[Title] => All Roads Lead to the International Motor Show (IAA) in Frankfurt
[Summary] => 
The International Motor Show in Frankfurt, celebrating its 60th year, broke records when the most number of visitors in its history came when it opened its doors to the public last Sept.13. It was not a surprise. After all, the show is one of the most important motor shows in the world attracting not only the most prestigious automakers, suppliers, designers but also people from all over the world.
[DatePublished] => 2003-09-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1793838
[AuthorName] => Yasmine C. Hidalgo
[SectionName] => Motoring
[SectionUrl] => motoring
[URL] =>
)
[9] => Array
(
[ArticleID] => 219500
[Title] => AsianLife Financial offers salary loans
[Summary] => AsianLife Financial Assurance Corp. (ALFA), formerly known as All Asia Life Assurance, is making a strong comeback with a basket full of goodies including an insurance product that serves as a salary loan.
ALFA is a subsidiary of regional financial giant ATR-Kim Eng Financial Corp. It acquired troubled All Asia Life last year and became full operational in March this year.
[DatePublished] => 2003-09-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Banking
[SectionUrl] => banking
[URL] =>
)
)
)
ALFA
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 814597
[Title] => The Guardian angel (19)
[Summary] => “ALFA?” Nakalapit na si Eric sa dalagang bulag.
[DatePublished] => 2012-10-13 00:00:00
[ColumnID] => 135886
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Pang Masa
[SectionUrl] => pang-masa
[URL] =>
)
[1] => Array
(
[ArticleID] => 487993
[Title] => Making good in a business of helping others
[Summary] => “I used to believe if you have money you can easily afford to get through an illness, but realized not if you are a dialysis patient,” thus said housewife Josephine Patricio, who has experienced the agony of taking care of his husband Lito who suffered kidney failure and is now undergoing dialysis treatments on its fourth year.
[DatePublished] => 2009-07-20 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
[2] => Array
(
[ArticleID] => 461231
[Title] => Through cell regeneration: Alfa brings renewed health and longer life
[Summary] => MANILA, Philippines - Do you desire to enjoy good health, long life and youthfulness?
[DatePublished] => 2009-04-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business As Usual
[SectionUrl] => business-as-usual
[URL] =>
)
[3] => Array
(
[ArticleID] => 410611
[Title] => Kapalpakan ng FEDEX
[Summary] => SA unang patustada pa lamang ni Alfa Mae Comendador ay malaki na ang tiwala nito sa Federal Express dahil ang company ...
[DatePublished] => 2008-10-28 00:00:00
[ColumnID] => 135127
[Focus] => 0
[AuthorID] => 1096558
[AuthorName] => Butch M. Quejada
[SectionName] => PSN Opinyon
[SectionUrl] => opinyon
[URL] =>
)
[4] => Array
(
[ArticleID] => 16664
[Title] => Tolerability key to success of hepatitis C treatment
[Summary] =>
[DatePublished] => 2007-09-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 300282
[Title] => New hepa B treatment outdoes standard care
[Summary] => A recent study shows that peginterferon alfa 2-a, a new hepatitis B treatment, provides a significantly greater proportion of patients with lasting remission compared to lamivudine, the current standard of care.
A study was conducted among patients with HbeAG positive hepatitis B, the subtype of the disease which affects majority of hepatitis B patients worldwide.
[DatePublished] => 2005-10-06 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 274759
[Title] => New hepa B treatment cited
[Summary] => At the recent 14th biennial conference of the Asian Pacific Association for the Study of the Liver, a new hepatitis B treatment option was cited.
Peginterferon alfa 2-a has been shown to treat both HbeAG-positive and HbeAG-negative chronic hepatitis B, thus removing the need for daily and potentially life-long therapy for the disease.
The studies presented during the conference showed that peginterferon alfa 2-a is superior to lamivudine, the most commonly prescribed medication for hepatitis B.
[DatePublished] => 2005-04-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 267041
[Title] => Current status of HCV therapy
[Summary] => Major advances have been made in the treatment of chronic hepatitis C during the last 10 years, but major challenges remain, since treatment with pegylated interferons and ribavirin is effective in only around 55 percent of patients. Newer therapies are needed for the increasing numbers of patients who do not respond to relapse after current treatments with pegylated in interferons and ribavirin.
[DatePublished] => 2004-12-05 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[8] => Array
(
[ArticleID] => 221854
[Title] => All Roads Lead to the International Motor Show (IAA) in Frankfurt
[Summary] => The International Motor Show in Frankfurt, celebrating its 60th year, broke records when the most number of visitors in its history came when it opened its doors to the public last Sept.13. It was not a surprise. After all, the show is one of the most important motor shows in the world attracting not only the most prestigious automakers, suppliers, designers but also people from all over the world.
[DatePublished] => 2003-09-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1793838
[AuthorName] => Yasmine C. Hidalgo
[SectionName] => Motoring
[SectionUrl] => motoring
[URL] =>
)
[9] => Array
(
[ArticleID] => 219500
[Title] => AsianLife Financial offers salary loans
[Summary] => AsianLife Financial Assurance Corp. (ALFA), formerly known as All Asia Life Assurance, is making a strong comeback with a basket full of goodies including an insurance product that serves as a salary loan.
ALFA is a subsidiary of regional financial giant ATR-Kim Eng Financial Corp. It acquired troubled All Asia Life last year and became full operational in March this year.
[DatePublished] => 2003-09-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Banking
[SectionUrl] => banking
[URL] =>
)
)
)
abtest
October 13, 2012 - 12:00am
September 27, 2007 - 12:00am
October 6, 2005 - 12:00am
September 2, 2003 - 12:00am
